Understanding the Role Prednisone in Reproductive Immunology
Introduction
For many people, experiencing repeated miscarriages, failed IVF cycles, or difficulty achieving a successful pregnancy can be heartbreaking and confusing. While chromosome abnormalities, hormonal problems, and anatomical issues are well-known causes of reproductive failure, researchers have also been studying the role of the immune system in reproduction.
One medication that is sometimes used in this area is prednisone, a corticosteroid that helps reduce inflammation and modify immune responses. Understanding why prednisone may be prescribed can help patients make informed decisions about their fertility care.
What Is Prednisone?
Prednisone is a medication that belongs to a group of drugs called corticosteroids. It works by calming down immune activity and reducing inflammation throughout the body.
Prednisone has been used for decades to treat conditions such as:
- Asthma
- Allergies
- Rheumatoid arthritis
- Lupus
- Other autoimmune diseases
In reproductive medicine, lower doses are often used with the goal of reducing excessive immune responses that may affect implantation or pregnancy.
Why Might Prednisone Be Used in Reproductive Failure?
Some fertility specialists prescribe prednisone when they suspect that immune-related inflammation may be contributing to:
Recurrent Pregnancy Loss
Women who experience multiple miscarriages may undergo testing for autoimmune or inflammatory conditions. In selected cases, prednisone may be used to help reduce immune activation that could interfere with early pregnancy.
Recurrent Implantation Failure
Some patients undergo several IVF embryo transfers with good-quality embryos but do not achieve pregnancy. When other explanations have been ruled out, immune-related factors may be considered.
Autoimmune Conditions
Patients with autoimmune diseases such as lupus, rheumatoid arthritis, or certain thyroid disorders may already be taking prednisone or similar medications. These conditions can sometimes affect reproductive outcomes.
Elevated Immune Activity
Some fertility specialists evaluate markers of immune activation and may recommend prednisone when they believe excessive inflammation could interfere with embryo implantation.
How Does Prednisone Affect the Immune System?
Prednisone can:
- Reduce inflammatory chemicals called cytokines
- Suppress certain immune cells
- Decrease immune reactions against tissues
- Promote a more balanced environment for implantation
The goal is not to “turn off” the immune system, but rather to reduce excessive immune responses that may negatively affect reproduction.
Does Prednisone Work for Everyone?
No.
This is one of the most important points for patients to understand.
Not all reproductive failure is caused by immune problems. In fact, the most common causes of miscarriage and IVF failure are often unrelated to the immune system.
Research on prednisone in fertility treatment has produced mixed results. Some studies suggest benefits in carefully selected patients, while others show little or no improvement in broader patient populations.
Because of this, many fertility specialists reserve prednisone for specific situations rather than prescribing it routinely to everyone.
Possible Benefits
In appropriately selected patients, potential benefits may include:
- Improved implantation rates
- Reduced inflammation
- Better pregnancy maintenance
- Support for patients with autoimmune disorders
- Improved reproductive outcomes in some immune-related conditions
However, these benefits are not guaranteed and vary significantly from person to person.
Potential Side Effects
Even at relatively low doses, prednisone can cause side effects.
Short-term side effects may include:
- Increased appetite
- Mood changes
- Difficulty sleeping
- Fluid retention
- Heartburn
- Elevated blood sugar
Long-term or higher-dose use may increase the risk of:
- High blood pressure
- Weight gain
- Bone loss
- Increased susceptibility to infections
For fertility treatment, prednisone is often used for a limited period, which generally reduces the risk of serious side effects.
Is There a Standard Prednisone Dose in Reproductive Immunology?
One of the most important things for patients to understand is that there is no universally accepted or standardized prednisone dosing protocol for reproductive immunology-related fertility treatment.
Unlike medications used for well-established medical conditions, prednisone use in reproductive immunology is often individualized. Different fertility specialists and reproductive immunologists may prescribe different doses, start treatment at different times, and continue therapy for varying lengths of time depending on the patient’s specific clinical situation.
The goal of treatment is not simply to prescribe prednisone, but to achieve an appropriate balance in the immune system that supports implantation and pregnancy while minimizing unnecessary immune suppression and medication side effects.
For this reason, many experts believe that treatment should be personalized and guided by careful monitoring of immune and inflammatory markers, as well as the patient’s reproductive history, underlying autoimmune conditions, response to treatment, and pregnancy progress.
Because the immune system changes throughout fertility treatment and pregnancy, some specialists adjust prednisone dosing over time rather than using a fixed regimen for all patients.
As reproductive immunology continues to evolve, many specialists advocate for an individualized approach rather than a “one-size-fits-all” prednisone protocol.
The Bottom Line
Prednisone is sometimes used in reproductive medicine to help manage immune-related factors that may contribute to recurrent miscarriage, implantation failure, or fertility challenges. It works by reducing inflammation and calming certain immune responses.
However, reproductive immunology remains a complex and evolving field. Prednisone is not appropriate for every patient, and its benefits appear to be greatest in carefully selected individuals with suspected immune-mediated reproductive problems.
References
- Sun Y, Zhang Y, Ma X, et al. Prednisone versus placebo and live birth in patients with recurrent implantation failure undergoing in vitro fertilization: A randomized clinical trial. JAMA. 2023;329(15):1278–1287.
DOI: https://doi.org/10.1001/jama.2023.5302 - Quenby S, Kalumbi C, Bates M, Farquharson R, Vince G. Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertility and Sterility. 2005;84(4):980–984.
DOI: https://doi.org/10.1016/j.fertnstert.2005.03.067 - Tang AW, Alfirevic Z, Quenby S. Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: A systematic review. Human Reproduction. 2011;26(8):1971–1980.
DOI: https://doi.org/10.1093/humrep/der164 - Dan S, Wei W, Yichao S, Hongbo C, Shenmin Y, Jiaxiong W. Effect of glucocorticoids on the outcome of pregnancy in women with unexplained recurrent pregnancy loss: A meta-analysis. American Journal of Reproductive Immunology. 2015;74(4):291–300.
DOI: https://doi.org/10.1111/aji.12399 - Li J, Wang Y, Xu X, et al. Distinct suppression of prednisone on endometrial immune cells in women with reproductive failure. American Journal of Reproductive Immunology. 2024.
DOI: https://doi.org/10.1111/aji.70151 - Christiansen OB, Kolte AM, Krog MC, et al. Live birth rate in women with recurrent pregnancy loss after in vitro fertilization and immunotherapy with intravenous immunoglobulin and prednisone. Journal of Clinical Medicine. 2022;11(7):1894.
DOI: https://doi.org/10.3390/jcm11071894 - Nørgaard-Pedersen C, Kesmodel US, Jørgensen MM, Christiansen OB, et al. Intravenous immunoglobulin and prednisolone in women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: A randomized, double-blind, placebo-controlled trial. BMJ Open. 2025;15:e106024.
DOI: https://doi.org/10.1136/bmjopen-2024-106024 - Lédée N, Petitbarat M, Rahmati M, Dubanchet S, Chaouat G. The role of endometrial immune profiling in recurrent implantation failure. Journal of Reproductive Immunology. 2016;108:27–34.
DOI: https://doi.org/10.1016/j.jri.2015.11.001 - Robertson SA, Care AS, Moldenhauer LM. Regulatory T cells in embryo implantation and the immune response to pregnancy. Journal of Clinical Investigation. 2018;128(10):4224–4235.
DOI: https://doi.org/10.1172/JCI122182 - Practice Committee of the American Society for Reproductive Medicine (ASRM). Evaluation and treatment of recurrent pregnancy loss: A committee opinion. Fertility and Sterility. 2023.
DOI: https://doi.org/10.1016/j.fertnstert.2023.02.019 - The Evidence–Practice Gap in Immunotherapy for Recurrent Pregnancy Loss. F&S Reports. 2025.
DOI: https://doi.org/10.1016/j.xfre.2025.100430 - American Society for Reproductive Immunology (ASRI). Evidence-based recommendations for immunotherapy in recurrent pregnancy loss and reproductive failure. 2025. (Guideline document).